{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-002140","form_type":"8-K","ticker":"ASPI","cik":"0001921865","company_name":"ASP Isotopes Inc.","filed_at":"2026-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.282497+00:00","generated_at":"2026-05-15T06:37:21.459379+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ASP Isotopes targets first commercial shipments in 2026 and >$300M EBITDA by 2031","bullets":["First commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 expected in Q2–Q3 2026.","Helium Phase 1 nameplate capacity of 58 MCF/day liquid helium expected by Q3 2026.","Cash, equivalents, and marketable securities totaled $333M as of Dec 31, 2025.","Acquired two U.S. radiopharmacies (Florida Oct 2025, South Carolina) for radiopharmaceutical expansion.","QLE submitted draft S-1 for public listing and signed MOU with large U.S. energy company for enriched uranium."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-002140","json":"https://secwatch.observer/filing/0001477932-26-002140.json","markdown":"https://secwatch.observer/filing/0001477932-26-002140.md","text":"https://secwatch.observer/filing/0001477932-26-002140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1921865/000147793226002140/0001477932-26-002140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1921865/000147793226002140/aspi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-15T06:37:21.459379+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}